Nursing home RSV vaccine study: does living situation affect protection?
NCT ID NCT06077149
Summary
This study compared how well two already-approved RSV vaccines work in adults over 60. Researchers wanted to see if people living in nursing homes had a similar immune response to the vaccines as people of the same age living independently in the community. All 152 participants received either the Pfizer or GSK RSV vaccine as part of their standard care, and their blood was tested before and after vaccination to measure the immune response.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESPIRATORY SYNCYTIAL VIRUS (RSV) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Rochester Medical Center
Rochester, New York, 14642, United States
Conditions
Explore the condition pages connected to this study.